Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice-Reference-Cited by-同舟云学术

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice

Published:2024-06-25 Issue:16 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Talvard-Balland Nana,Braun Lukas M.^ORCID,Dixon Karen O.,Zwick Melissa,Engel Helena,Hartmann Alina,Duquesne Sandra^ORCID,Penter Livius^ORCID,Andrieux Geoffroy^ORCID,Rindlisbacher Lukas,Acerbis Andrea,Ehmann Jule,Köllerer Christoph,Ansuinelli Michela,Rettig Andres,Moschallski Kevin,Apostolova Petya,Brummer Tilman,Illert Anna L.,Schramm Markus A.^ORCID,Cheng Yurong,Köttgen Anna^ORCID,Duyster Justus,Menssen Hans D.,Ritz Jerome^ORCID,Blazar Bruce R.^ORCID,Boerries Melanie^ORCID,Schmitt-Gräff Annette,Sariipek Nurefsan,Van Galen Peter,Buescher Joerg M.,Cabezas-Wallscheid Nina,Pahl Heike L.^ORCID,Pearce Erika L.,Soiffer Robert J.,Wu Catherine J.,Vago Luca^ORCID,Becher Burkhard^ORCID,Köhler Natalie^ORCID,Wertheimer Tobias,Kuchroo Vijay K.,Zeiser Robert^ORCID

Funder

Deutsche Forschungsgemeinschaft

European Research Council

Leukemia and Lymphoma Society

National Institutes of Health

Swiss National Science Foundation

Deutsche Krebshilfe

Publisher

American Society for Clinical Investigation

Link

https://www.jci.org/articles/view/177460/files/pdf

Reference69 articles.

1. Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

2. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

3. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

4. Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

5. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells